Glenmark Generics is a finished-dose manufacturer based in Argentina. It appears in 13 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 27 May 2014 as VAI. Customs aggregates show $6.0M of exports covering 77 molecules to 11 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| BUENOS AIRES, Argentina | Not on file |
| Argentina, Argentina | 3009805225 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ANMAT (AR) | 13 | None |
| ANVISA (Brazil) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $6.0M | 11 |
| 2024 | Not reported | $10.5M | 13 |
| 2023 | Not reported | $3.2M | 13 |
| 2022 | Not reported | $5.4M | 12 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Glenmark Generics comes back tiered against every other supplier able to file there.
Start for free